Colbert Roasts Trump Mobile on Final Show

 

Sponsored by Cardiol Therapeutics

Colbert Roasts Trump Mobile on Final Show

 

Talk show host Stephen Colbert’s final-week swipe at Trump Mobile landed because the joke had receipts: a $47.45 wireless plan, a delayed gold phone, shifting US-manufacturing language, alleged customer-data exposure, and a political brand now being judged by ordinary consumer-tech standards.

On the penultimate episode of The Late Show, Colbert mocked the Trump family’s wireless venture and its T1 Phone, turning a loyalty-branded product launch into late-night shorthand for overpromising. The Daily Beast reported that the bit drew on the phone’s delay, its patriotic marketing, its resemblance to overseas models identified by other outlets, and a design flaw involving the flag graphic.

“As for the phone, let’s be clear: This thing sucks!” Colbert said.

You can read more on the matter here.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. Cardiol has received Investigational New Drug Application authorization from the US FDA to conduct clinical studies to evaluate the efficacy and safety of CardiolRx™ in two diseases affecting the heart: recurrent pericarditis and acute myocarditis.

What’s going on?

  • Trump-Appointed Arts Panel Approved Trump’s 250-ft Washington Arch (theDeepDive)

  • Trump Collides With GOP Senators Over $1.8 Billion ‘Anti-Weaponization’ Fund (WSJ)

  • Canada’s Retirement Backstop Misses Its Own Benchmark Again — and the Gap Is Getting Harder to Explain (theDeepDive)

  • Canadian military to shutter Nanisivik naval facility in the Arctic (CTV)

  • EXIM Board Set to Vote Thursday on ExportAI Initiative Financing U.S. AI Sales Abroad (theDeepDive)

  • Poilievre says he'll campaign to keep Alberta in the 'Canadian family' as a referendum looms (CBC)

  • Two Pro-Canada Alberta Cabinet Ministers Quit Ahead of Smith’s Shuffle (theDeepDive)

  • Donald Trump abruptly postpones AI order after White House infighting (FT)

  • Iran Deal in ‘Final Stages,’ Trump Says, as New Details Reveal Deep Sticking Points (theDeepDive)

  • Mortgage Rates Hit a Nine-Month High in Blow to Prime Buying Season (WSJ)

What’s the latest?

  • Tech: Microsoft is reportedly in talks to supply its Maia AI chips to Anthropic, a move that could help Microsoft compete more directly with Amazon and Google in the fast-growing AI infrastructure market. Anthropic’s rising popularity — especially with Claude and Claude Code — has increased its demand for computing power, with the company already relying on Nvidia GPUs and custom chips from Amazon and Google. A deal would also be a major validation for Microsoft’s Maia 200 chips, which the company says deliver over 30% better efficiency compared to previous hardware.

  • Trade War: A new Deloitte report says Canada’s heavy dependence on the U.S. left many businesses unprepared when President Donald Trump imposed sweeping tariffs on Canadian imports last year. The report found companies with more globally diversified operations adapted faster, while many Canadian firms lacked flexible supply chains and even basic CUSMA compliance paperwork. Deloitte says Canada’s long-term trade competitiveness has weakened over the past two decades, and future success will depend on building more resilient, diversified, and adaptable trade strategies.

  • Stellantis: Stellantis unveiled a €60 billion (US$70 billion) five-year strategy under new CEO Antonio Filosa focused on partnerships, affordable vehicles, and improving factory efficiency. The company plans to launch 60 new models by 2030 while concentrating most investments on core brands like Jeep, Ram, Peugeot, and Fiat. Investors reacted cautiously, sending shares down more than 5% amid concerns about execution and the company’s ability to deliver on its long-term goals.

  • Energy: Canadian oil and gas executives say Prime Minister Mark Carney’s new energy deal with Alberta has improved the country’s appeal for energy investment by easing regulations and supporting faster project approvals. The agreement could pave the way for a new 1-million-barrel-per-day pipeline to British Columbia, though companies warn Canada still faces cost and competitiveness challenges versus the U.S. Industry leaders say filling the proposed pipeline would require up to $100 billion in new oil sands investments and stronger long-term policy certainty.

  • Markets: Canada’s main stock index rose nearly 100 points Thursday, boosted by energy stocks as oil prices climbed back above US$100 per barrel. Meanwhile, U.S. markets traded lower, with losses in the Nasdaq leading declines. The Canadian dollar weakened slightly to 72.50 cents US, while gold prices also fell.

Equinox X Orla

The stock market and stuff

  • SpaceX S-1 Reveals Anthropic Is Paying $1.25 Billion a Month for AI Compute (theDeepDive)

  • SpaceX Files For IPO, xAI Losses Loom Large (theDeepDive)

  • Miner Perpetua Resources secures $2.9 billion U.S. loan for Idaho gold, antimony project (CNBC)

  • Hong Kong Targets London’s Gold Crown With July Clearing Launch and 11-Bank Board (theDeepDive)

In the juniors

  • Questcorp Wraps Expanded Drone Survey at La Union as Summer Drilling Approaches (theDeepDive)

  • Sherritt Agrees to Hand Majority Stake to Trump-Linked Investor as Cuba Sanctions Bite (theDeepDive)

  • Hemlo Mining Posts $186.3 Million in Revenue in Debut Quarter (theDeepDive)

FULL DISCLOSURE: Cardiol Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cardiol Therapeutics. The author has been compensated to cover Cardiol Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.